Paramount (PGRE)
Market Price (11/8/2025): $6.55 | Market Cap: $1.4 Bil
Sector: Real Estate | Industry: Office REITs
Paramount (PGRE)
Market Price (11/8/2025): $6.55
Market Cap: $1.4 Bil
Sector: Real Estate
Industry: Office REITs
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 24%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 24% | Weak multi-year price returns 2Y Excs Rtn is -16%, 3Y Excs Rtn is -68% | Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 234% |
| Attractive yield FCF Yield is 12% | Weak revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -5.3%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -0.7%, Rev Chg QQuarterly Revenue Change % is -11% | |
| Low stock price volatility Vol 12M is 35% | Valuation getting more expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 61% | |
| Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -11% |
| Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 24%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 24% |
| Attractive yield FCF Yield is 12% |
| Low stock price volatility Vol 12M is 35% |
| Weak multi-year price returns 2Y Excs Rtn is -16%, 3Y Excs Rtn is -68% |
| Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 234% |
| Weak revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -5.3%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -0.7%, Rev Chg QQuarterly Revenue Change % is -11% |
| Valuation getting more expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 61% |
| Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -11% |
Market Valuation & Key Metrics
PGRE Stock
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| PGRE Return | -32% | -5% | -26% | -9% | -3% | 33% | -44% |
| Peers Return | -15% | 26% | -40% | -3% | -15% | -16% | -55% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 14% | 108% |
Monthly Win Rates [3] | |||||||
| PGRE Win Rate | 42% | 50% | 42% | 50% | 42% | 40% | |
| Peers Win Rate | 35% | 57% | 37% | 48% | 43% | 48% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 70% | |
Max Drawdowns [4] | |||||||
| PGRE Max Drawdown | -57% | -11% | -31% | -32% | -17% | -20% | |
| Peers Max Drawdown | -42% | -7% | -45% | -38% | -29% | -27% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: HIW, HPP, PSTL, FSP, ARE.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 11/7/2025 (YTD)
How Low Can It Go
| Event | PGRE | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -64.9% | -25.4% |
| % Gain to Breakeven | 184.7% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -61.6% | -33.9% |
| % Gain to Breakeven | 160.4% | 51.3% |
| Time to Breakeven | Not Fully Recovered days | 148 days |
| 2018 Correction | ||
| % Loss | -29.8% | -19.8% |
| % Gain to Breakeven | 42.4% | 24.7% |
| Time to Breakeven | Not Fully Recovered days | 120 days |
Compare to HIW, HPP, PSTL, FSP, ARE
In The Past
Paramount's stock fell -64.9% during the 2022 Inflation Shock from a high on 6/9/2021. A -64.9% loss requires a 184.7% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select past ideas related to PGRE. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 10312025 | MPW | Medical Properties Trust | Special | Short Squeeze PotentialShort Squeeze Potential Has potential for a short squeeze. High short interest, rising short interest and high debt. | -1.9% | -1.9% | -5.8% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 10312025 | MPW | Medical Properties Trust | Special | Short Squeeze PotentialShort Squeeze Potential Has potential for a short squeeze. High short interest, rising short interest and high debt. | -1.9% | -1.9% | -5.8% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Paramount
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 11.06 |
| Mkt Cap | 1.2 |
| Rev LTM | 754 |
| Op Inc LTM | 69 |
| FCF LTM | 106 |
| FCF 3Y Avg | 191 |
| CFO LTM | 117 |
| CFO 3Y Avg | 200 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -3.8% |
| Rev Chg 3Y Avg | -0.6% |
| Rev Chg Q | -6.0% |
| QoQ Delta Rev Chg LTM | -1.5% |
| Op Mgn LTM | 16.9% |
| Op Mgn 3Y Avg | 20.4% |
| QoQ Delta Op Mgn LTM | -0.8% |
| CFO/Rev LTM | 34.3% |
| CFO/Rev 3Y Avg | 38.1% |
| FCF/Rev LTM | 34.3% |
| FCF/Rev 3Y Avg | 37.3% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 1.2 |
| P/S | 2.6 |
| P/EBIT | 4.1 |
| P/E | -2.4 |
| P/CFO | 8.9 |
| Total Yield | -0.7% |
| Dividend Yield | 3.7% |
| FCF Yield 3Y Avg | 11.5% |
| D/E | 1.8 |
| Net D/E | 1.6 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -13.0% |
| 3M Rtn | -3.9% |
| 6M Rtn | 0.2% |
| 12M Rtn | -22.8% |
| 3Y Rtn | -23.9% |
| 1M Excs Rtn | -9.7% |
| 3M Excs Rtn | -9.5% |
| 6M Excs Rtn | -18.7% |
| 12M Excs Rtn | -37.4% |
| 3Y Excs Rtn | -101.0% |
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 10/29/2025 | 0.0% | 0.2% | |
| 7/30/2025 | 1.5% | 7.8% | 17.2% |
| 2/27/2025 | -2.0% | -6.7% | -7.6% |
| 10/30/2024 | -4.0% | 1.8% | -3.8% |
| 7/31/2024 | -3.4% | -10.5% | -5.5% |
| 5/1/2024 | 3.9% | 3.7% | -1.5% |
| 2/14/2024 | 7.6% | 2.0% | 2.4% |
| 11/1/2023 | 9.4% | 3.3% | 19.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 12 | 12 | 10 |
| # Negative | 11 | 11 | 13 |
| Median Positive | 1.8% | 2.0% | 8.5% |
| Median Negative | -2.7% | -5.3% | -5.1% |
| Max Positive | 9.4% | 15.3% | 73.2% |
| Max Negative | -7.4% | -15.7% | -33.3% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 10292025 | 10-Q 9/30/2025 |
| 6302025 | 7302025 | 10-Q 6/30/2025 |
| 3312025 | 4302025 | 10-Q 3/31/2025 |
| 12312024 | 2272025 | 10-K 12/31/2024 |
| 9302024 | 10302024 | 10-Q 9/30/2024 |
| 6302024 | 7312024 | 10-Q 6/30/2024 |
| 3312024 | 5012024 | 10-Q 3/31/2024 |
| 12312023 | 2142024 | 10-K 12/31/2023 |
| 9302023 | 11012023 | 10-Q 9/30/2023 |
| 6302023 | 7312023 | 10-Q 6/30/2023 |
| 3312023 | 5032023 | 10-Q 3/31/2023 |
| 12312022 | 2152023 | 10-K 12/31/2022 |
| 9302022 | 10262022 | 10-Q 9/30/2022 |
| 6302022 | 7262022 | 10-Q 6/30/2022 |
| 3312022 | 4272022 | 10-Q 3/31/2022 |
| 12312021 | 2222022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.